Contrarian Investor: The impact of our dividend fetish

'Obsession with dividends benefits the wealthy'

Contrarian Investor: The impact of our dividend fetish

It has been a bumper few weeks for world class research reports and white papers trying to explain the strange, populist times we are living in.

The stand-out paper is from a US research outfit called the Brookings Institution called Mortality and Morbidity in the 21st Century. It is co-authored by the husband and wife team of Anne Case and Nobel Prize winner Angus Deaton, from Princeton University, and is a forensic analysis of what is going wrong within white working class America - and why it will be so difficult to fix.  The latest white paper from asset management firm GMO by contrast is not quite as forensic in its evidence gathering, but it is nevertheless an equally damning analysis, with a range of investment implicat...

To continue reading this article...

Join Investment Week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week


More on Equities

Industry Voice: T. Rowe Price's 2022 Midyear Market Outlook summary

Industry Voice: T. Rowe Price's 2022 Midyear Market Outlook summary

Transitioning to a new paradigm

Ritu Vohora, Investment Specialist, Capital Markets at T. Rowe Price
clock 23 June 2022 • 2 min read
Amazon shares are down 40% from its peak

Growth stock pickers feel like 'a kid in a candy shop'

'It is time to go shopping'

clock 22 June 2022 • 4 min read
Sectors in the US stock market that have been leaders over the last decade have come to a sudden stop in terms of their outperformance of the broader market since the start of 2022.

Deep Dive: A paradigm shift for US equities

'Valuations matter'

clock 15 June 2022 • 5 min read